Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells

Neuroblastoma (NB) is the most common extracranial solid tumor in children and, in the high-risk group, has a 5-year mortality rate of ~50%. The high mortality rate and significant treatment-related morbidities associated with current standard of care therapies belie the critical need for more toler...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: McNerney, Kevin O., Karageorgos, Spyridon A., Hogarty, Michael D., Bassiri, Hamid
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225357/
https://ncbi.nlm.nih.gov/pubmed/32457760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00873
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items